UroGen Pharma Announces Pricing Of Public Offering Of Shares And Pre-Funded Warrants

(RTTNews) – UroGen Pharma Ltd. (URGN) announced the pricing of an underwritten public offering of 5 million ordinary shares at a price to the public of $17.50 per ordinary share, and, to certain investors in lieu of issuing ordinary shares, pre-funded warrants to purchase 1.14 mi

admin